# Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery

> **NCT00003901** · PHASE3 · COMPLETED · sponsor: **Alliance for Clinical Trials in Oncology** · enrollment: 1310 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **OTHER:** immunohistochemistry staining method
- **PROCEDURE:** biopsy
- **PROCEDURE:** surgery

## Key facts

- **NCT ID:** NCT00003901
- **Lead sponsor:** Alliance for Clinical Trials in Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-07
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 1310 (ACTUAL)
- **Last updated:** 2017-02-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003901, "Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00003901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*